Sunshine Biopharma plans up to $4 million at-the-market share sale via Aegis Capital

Reuters2026/07/20 20:28

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Sunshine Biopharma set up an at-the-market equity program to sell up to USD 4 million of common stock over time on Nasdaq.
Aegis Capital will act as exclusive sales agent, earning a 3% commission on gross proceeds.
The program gives the company flexibility to raise capital opportunistically, with no obligation to sell any shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sunshine Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-005656), on July 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Sunshine Biopharma plans up to $4 million at-the-market share sale via Aegis Capital

You may also like

Crypto prices